Abstract:This study investigates the regulatory effect of plasmacytoid dendritic cells (pDC)/myeloid dendritic cells (mDC) imbalance on balance of Th1/Th2 and Th17/Treg in primary immune thrombocytopenia (ITP). A total of 30 untreated ITP patients and 20 healthy controls were recruited. Compared with healthy control, the pDC proportion of ITP patients was significantly reduced ( P = 0.004), while the mDC proportion was not significantly changed ( P = 0.681), resulting in a decrease in the pDC/mDC ratio ( P = 0.001). Additionally, compared with controls, serum levels of interleukin (IL)-6, IL-12, and IL-23 were increased in ITP patients ( P < 0.001), and mRNA levels of IL-12p40, IL-12p35, and IL-23p19 were also increased ( P =0.014, P = 0.043, P < 0.001). Compared with the healthy control, the proportion of Th1 and Th17 cells in ITP patients increased ( P = 0.001, P = 0.031). Serum levels of interferon gamma (IFN-γ) and IL-17 in ITP patients also increased ( P = 0.025, P = 0.005). Furthermore, T-bet and RORγt mRNA levels were increased in peripheral blood of ITP patients ( P = 0.018, P < 0.001). Correspondingly, the proportion of Th2 and Treg cells decreased ( P = 0.007, P < 0.001), along with a decrease in serum IL-4 and transforming growth factor beta (TGF-β) ( P = 0.028, P = 0.042), and an increase in GATA-3 mRNA ( P < 0.001). However, there was no significant difference in Foxp3 mRNA levels ( P = 0.587). Pearson correlation analysis showed that the proportion of total dendritic cells (DCs) was positively correlated with IL-12 ( r = 0.526, P = 0.003) and IL-23 ( r = 0.501, P = 0.005) in ITP patients. Th1/Th2 ratio, IFN-γ, and IL-12 levels were negatively correlated with platelet counts ( r = −0.494, P = 0.009; r = –0.415, P = 0.028; r = –0.492, P = 0.032). However, IL-23 was positively correlated with IL-17 ( r = 0.489, P = 0.006) and negatively correlated with platelet count ( r = –0.564, P = 0.001). The ratio of IL-6 and Th17 cells was negatively correlated with platelet count ( r = –0.443, P = 0.014; r = –0.471, P = 0.011). The imbalance of pDC/mDC and the increase of IL-6, IL-12, and IL-23 lead to the increased differentiation of CD4+ T cells into Th1 and Th17 cells, which might be the important mechanisms underlying the imbalance of Th1/Th2 and Th17/Treg in ITP patients.

[The Role of Interleukin-18 and Interleukin-18 Receptor in Predominant Th1 Immune Response of Patients with Immune Thrombocytopenia].

[Expression of Interleukin-18 and Interleukin-18 Receptor Alpha Chain of the Peripheral White Blood Cells in Immune Thrombocytopenia].

Changes in Follicular Helper T Cells in Idiopathic Thrombocytopenic Purpura Patients.

[Imbalance of Th17/Treg Cells Ratio in Peripheral Blood of Patients with Immune Thrombocytopenia].

Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia

[Role of IL-18/IL-18BP Balance in Spleen of Patients with Primary Immune Thrombocytopenia].

Interleukin 18 and Interleukin 18 Binding Protein in Patients with Idiopathic Thrombocytopenic Purpura

In Vitro Recovery of Th1/Th2 Balance in PBMCs from Patients with Immune Thrombocytopenia Through the Actions of IL-18BPa/Fc

The Role of IL-23/Th17 Pathway in Patients with Primary Immune Thrombocytopenia

Elevated Interleukin-21 Correlated to Th17 and Th1 Cells in Patients with Immune Thrombocytopenia

[Impaired Interleukin-10 Secretion by CD5(+) B Cells in Patients with Primary Immune Thrombocytopenia].

Elevated Profiles of Th22 Cells and Correlations with Th17 Cells in Patients with Immune Thrombocytopenia

Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia

CCR6 Defines a Subset of Activated Memory T Cells of Th17 Potential in Immune Thrombocytopenia.

Aberrant Frequency of IL-10-producing B Cells and Its Association with Treg/Th17 in Adult Primary Immune Thrombocytopenia Patients.

The Expression Profile of Toll-Like Receptor Signaling Molecules in Cd19(+) B Cells from Patients with Primary Immune Thrombocytopenia

Interleukin-17-producing CD4+ T Lymphocytes Are Increased in Patients with Primary Immune Thrombocytopenia.

Excessive Expressions of T Cell Activation Markers in Pediatric Immune Thrombocytopenia

Regulation of Th1/Th2 and Th17/Treg by pDC/mDC imbalance in primary immune thrombocytopenia

Decreased expression of interleukin-27 in immune thrombocytopenia.

Profile of Th17 Cytokines (IL-17, TGF-β, IL-6) and Th1 Cytokine (Ifn-Γ) in Patients with Immune Thrombocytopenic Purpura